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Clinical PerspectiveWhat Is New?Left atrial dynamics differ between young cryptogenic ischemic stroke patients and healthy controls.This finding supports the hypothesis that underlying pathophysiology is cardioembolism in part of the early‐onset cryptogenic strokes.What Are the Clinical Implications?Although the results give a clue regarding disease mechanism, more research is needed to explore whether altered left atrial dynamics should alter current secondary prevention options.
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Introduction {#jah34958-sec-0008}
============

Ischemic stroke can occur because of cardioembolism. Some cardiac diseases are categorized as high‐risk sources because of an \>2% annual ischemic stroke risk.[1](#jah34958-bib-0001){ref-type="ref"} A portion of ischemic strokes remain cryptogenic, that is, with undetermined etiology despite intensive diagnostic investigations. Stroke at younger ages is particularly prone to be of a cryptogenic nature,[2](#jah34958-bib-0002){ref-type="ref"} when there is limited evidence for targeted secondary prevention and counseling on prognosis.

Embolic stroke of undetermined source (ESUS) is a new concept of stroke etiology and represents a defined subgroup of cryptogenic stroke, in which the patient has a neuroimaging pattern typical for embolic strokes, which excludes deep, that is, lacunar, infarctions. In ESUS, no definite source of embolism may be found, which also excludes high‐risk sources of cardioembolism.[3](#jah34958-bib-0003){ref-type="ref"} Intensive research has been focused on the possibility of at least part of the ESUS cases being of cardiac origin, whereas ESUS remains a heterogeneous patient group.[4](#jah34958-bib-0004){ref-type="ref"} Also, there is no hard evidence that some lacunar infarctions could not originate from cardioembolic sources.[5](#jah34958-bib-0005){ref-type="ref"} Silent atrial fibrillation (AF) is also thought to be the embolic source for part of the ESUS patients, although symptom severity of ESUS and AF‐related strokes does not match.[6](#jah34958-bib-0006){ref-type="ref"} However, AF is rare in young people, and hence most cryptogenic strokes in the young, including ESUS cases, are most likely not attributable to silent AF.[7](#jah34958-bib-0007){ref-type="ref"} Studies suggest that some ESUS patients have slight differences in cardiac structure and function, compared with stroke patients with an established noncardiac stroke etiology. These include left atrial (LA) appendage (LAA) morphology, *P*‐wave terminal force on ECG, and LA enlargement.[8](#jah34958-bib-0008){ref-type="ref"}, [9](#jah34958-bib-0009){ref-type="ref"} A theory on atrial cardiopathy has emerged, and a pathological thrombogenic atrial substrate is thought to be one of the factors in ESUS pathogenesis.[8](#jah34958-bib-0008){ref-type="ref"} Atrial cardiopathy can be principally a reflection of the same pathology as AF, that is, LA remodeling occurring in patients with AF.[10](#jah34958-bib-0010){ref-type="ref"} However, cardiac findings in particularly young ESUS and cryptogenic stroke patients (aged \<50 years) have been described very scarcely in the literature---one of the findings being thicker epicardial fat.[11](#jah34958-bib-0011){ref-type="ref"}

We sought to evaluate whether advanced echocardiography methods can detect differences in LA mechanical function between young cryptogenic stroke patients and stroke‐free controls and hence signs of atrial cardiopathy even at a young age.

Methods {#jah34958-sec-0009}
=======

Study Population {#jah34958-sec-0010}
----------------

The data that support the findings of this study are available from the corresponding author upon reasonable request. All participants in this study were recruited among those enrolled into the SECRETO (Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Etiology, Triggers, and Outcome) Trial (NCT01934725), which is an international, prospective, multicenter, case‐control study of young adults (aged 18--49 years) presenting with an imaging‐positive first‐ever ischemic stroke of undetermined etiology. The study protocol has been published in more detail.[12](#jah34958-bib-0012){ref-type="ref"} Patients were included after standardized diagnostic procedures, including brain magnetic resonance imaging, imaging of intra‐ and extracranial arteries with either computed tomography angiography or magnetic resonance angiography, and cardiac imaging to rule out established causes of ischemic stroke. Hence, no patients with causally relevant aortic or carotid pathology were included. Cardiac imaging included standardized transthoracic and ‐esophageal echocardiography.[13](#jah34958-bib-0013){ref-type="ref"} We screened for AF with ≥24‐hour Holter monitoring. Patients were classified according to ESUS criteria[3](#jah34958-bib-0003){ref-type="ref"} as ESUS (+) and ESUS (--).

Patients were age and sex matched to stroke‐free controls in a 1:1 fashion. A list of 20 potential controls per 1 patient were randomly identified from the Population Registry, with an invitation letter sent to controls 1 by 1. If this strategy did not result in a fit, willing control person, patients' nonrelated proxies or proxies of the study personnel were recruited. Detailed clinical history was recorded from all study subjects, including arterial blood pressure, height, weight, alcohol consumption, and presence of right‐to‐left shunt. The definition of right‐to‐left shunt was a positive finding on either transesophageal echocardiography or transcranial Doppler bubble test, and each patient and control underwent at least one of these tests. Participants were dichotomized according to their right‐to‐left shunt status. Patients with previous patent foramen ovale closure were excluded from this substudy.

The inclusion period for this substudy was from December 2013 to May 2017. Written informed consent was obtained from all study subjects. The SECRETO has been approved by the ethics committee of Helsinki and Uusimaa Hospital District.

Echocardiography Methods {#jah34958-sec-0011}
------------------------

The same echocardiographist (J.Pi.) examined all patients and control subjects blinded to the case‐control status with a General Electric Vivid E9 version 113 cardiac ultrasound device, using M5Sc and 4V probes (General Electric, Horten, Norway). Basic left ventricular (LV) measurements were obtained from the parasternal long‐axis view. Measurements of mitral inflow E wave and A wave were obtained from the apical 4‐chamber view using the pulsed wave Doppler, and e' velocity was measured using tissue Doppler imaging. Tricuspid regurgitation velocity was assessed from a projection optimized to the regurgitation jet. Diastolic function of patients and controls was evaluated using the American Society of Echocardiography and European Association of Cardiovascular Imaging guidelines, with a modification of LA volume (LAV) index, which was measured with 4‐dimensional (4D) volumetry and not using the Simpson method, given that it is more sensitive using the same cut‐off value of 34 mL/m^2^.[14](#jah34958-bib-0014){ref-type="ref"}

From the apical view, both LV and LA 2‐dimensional measurements and 4D measurements were obtained. A true apical view was verified using the triplane mode. The apical 4‐chamber view was defined as long‐axis trans‐secting the LV apex and the mitral orifice and maximizing the LV and right ventricular area. The 2‐chamber view was defined as a counterclockwise virtual rotation of 60 degrees, hence viewing the LV and LA. The 3‐chamber view was defined as a further counterclockwise virtual rotation of 60 degrees, hence viewing the LV, ascending aorta, and LA. In addition to these 3 planes, a fine‐tuned virtual rotation was used to obtain an apical view where the LAA orifice was as large as possible, used only for the LAA orifice minimum and maximum measurements. LAA orifice variation was defined as (LAA orifice maximum)−(LAA orifice minimum) and LAA orifice relative variation as (maximum‐minimum)/maximum (Figure [1](#jah34958-fig-0001){ref-type="fig"}).

![**Rotation angle optimized for left atrial appendage orifice measurement.**\
In this case, the optimal angle was at −55 degrees (compare: 4‐chamber view is 0 degrees and 2‐chamber view is −60 degrees). Measurement at end of ventricular diastole was 9 mm and at end of ventricular systole 21 mm. Hence, the variation was 12 mm and the relative variation 57%.](JAH3-9-e014578-g001){#jah34958-fig-0001}

LV 4D measurements were obtained from an apical view using multibeat acquisition of 6 cardiac cycles, zoomed in for only the LV, obtaining ≈50 volumes per second. The LV stroke volume was used for calculation of the LA conduit volume.[15](#jah34958-bib-0015){ref-type="ref"} LAV was determined using the 4D method, zoomed in for only the LA, and using a 4‐cycle multibeat method with a volume rate of ≈50 volumes per second. LAV was analyzed in 4 stages of the cardiac cycle, from the volume‐time curve: maximum volume (LAVmax) at the end of ventricular systole, mid‐diastolic volume after the passive emptying phase, late diastolic volume just before atrial contraction, and minimum volume (LAVmin) after atrial contraction, at the end of ventricular diastole. LA reservoir volume was defined as the volume difference between LAVmax and LA mid‐diastolic volume.[15](#jah34958-bib-0015){ref-type="ref"} LA stroke volume was defined as (LA late diastolic volume−LAVmin), and LA ejection fraction was defined as (LA stroke volume/LA late diastolic volume). LA cyclic volume change was defined as LAVmax−LAVmin (Figure [2](#jah34958-fig-0002){ref-type="fig"}). LA passive emptying percentage was defined as 100\*(LAVmax--LA late diastolic volume)/(LAVmax−LAVmin).[16](#jah34958-bib-0016){ref-type="ref"} LA conduit volume, as a measurement of blood flow passing through the LA without affecting its volume, was defined as LV stroke volume−LA reservoir volume--LA stroke volume, which was adequate, given that none of the patients had significant mitral regurgitation or continuous left‐to‐right or right‐to‐left shunts.[15](#jah34958-bib-0015){ref-type="ref"} LA sphericity index was analyzed using the LV sphericity index function of EchoPAC version 113 (GE Healthcare 2013).

![**4D analysis of left atrial volume cycle and definitions of the 4 volumetric measurement points: left atrial minimum volume (LAVmin), left atrial maximum volume (LAVmax), left atrial mid‐diastolic volume (LAMDV), and left atrial late diastolic volume (LALDV).**\
In this patient, LAVmin was 20 mL and LAVmax 50 mL; hence, left atrial cyclic volume change was 30 mL. LAMDV was 28 mL, and hence LA reservoir volume was 22 mL. LALDV was 31 mL, and hence LA stroke volume was 11 mL and LA ejection fraction 11/31 mL=35%. Given that this patient had a left ventricular stroke volume (LVSV) of 87 mL, the left atrial conduit volume was 54 mL (LVSV -- LA reservoir volume -- LA stroke volume). 4D indicates 4‐dimensional; and LA, left atrium.](JAH3-9-e014578-g002){#jah34958-fig-0002}

We also studied LA longitudinal strain using the *P* wave for ECG gating, a method known as epsilon (Figure [3](#jah34958-fig-0003){ref-type="fig"}).[17](#jah34958-bib-0017){ref-type="ref"} We measured LA strain rate using tissue Doppler imaging in accordance with Safir‐Mardanloo\'s method for each wall in all 3 apical projections, although only at mid‐level (Figure [4](#jah34958-fig-0004){ref-type="fig"}).[18](#jah34958-bib-0018){ref-type="ref"} We performed body surface area indexing for LAVs and LAA orifice measurements using the Mosteller formula.[19](#jah34958-bib-0019){ref-type="ref"}

![**LA epsilon analysis. Note the ECG gating set at the *P* wave.**\
Following the dotted white line, expressing the epsilon of the entire left atrium, a negative maximum of 12.5 can be noted in the 4‐chamber view and a negative maximum of 12.6 in the 2‐chamber view. The positive maximums are 33.8 and 20.6, respectively. Hence, the global negative epsilon peak was 12.6 and the global positive epsilon peak 27.2, calculated as means of the 2 views. LA indicates left atrium.](JAH3-9-e014578-g003){#jah34958-fig-0003}

![**LA strain rate (SR) using tissue Doppler imaging of the 6 mid‐level points of the LA, in all 3 the apical projections (upper 4‐chamber, middle 2‐chamber, and lower 3‐chamber).**\
The 3 SR measurements of the septum are −1.9, −2.6, and −2.2, hence the mean is −1.7. The means of the lateral, inferior, anterior, posterior, and anteroseptal walls are −4.5, −1.7, −1.4, −2.4, and −2.6, respectively. Hence, the global mean is −2.38 for this patient. LA indicates left atrium.](JAH3-9-e014578-g004){#jah34958-fig-0004}

Statistical Analysis {#jah34958-sec-0012}
--------------------

We used the Wilcoxon signed‐rank test for examining differences between groups. Maximum tertile was defined as the highest tertile of measurements for both patient and control groups and minimum tertiles as the lowest tertile of measurements for both patient and control groups. Tertiles were analyzed comparing the most pathological tertile of the patient group and control group, for each parameter. For dichotomous baseline parameters, we used the McNemar test. We did a sensitivity analysis based on right‐to‐left shunt status using the Mann--Whitney *U* test. All analyses used IBM SPSS (version 22; IBM Corp., Armonk, NY) or RStudio software (version 1.2.1335; RStudio, Boston, MA).

Results {#jah34958-sec-0013}
=======

We included a total of 30 patients, of which 22 (73.3%) fulfilled criteria for ESUS. Of the 30 controls, 23 were identified from the Population Registry. Compared with controls, patients had a higher body weight and body mass index and a larger body surface area. We found no significant differences between patients and controls regarding other established cardiovascular risk factors. Patients had a higher prevalence of right‐to‐left shunt (Table [1](#jah34958-tbl-0001){ref-type="table"}). None of our patients or controls had chronic kidney disease. Patients had significantly higher usage of antiplatelets, statins, and angiotensin‐converting enzyme inhibitors/angiotensin‐converting enzyme blockers than controls (Table [1](#jah34958-tbl-0001){ref-type="table"}).

###### 

Baseline Clinical Data of Patients and Controls

                                    Patients      Controls      *P* Value
  --------------------------------- ------------- ------------- -----------
  Body measurements                                             
  Height                            172 (14)      168 (16)      0.069
  Weight                            86.8 (30)     75.5 (27)     0.012
  Waist circumference, cm           98.8 (19.8)   88.5 (19.9)   0.015
  Body mass index                   30.2 (7.2)    26.1 (6.7)    0.026
  Body surface area                 2.04 (0.44)   1.88 (0.41)   0.007
  Systolic blood pressure           128 (21)      129 (21)      0.256
  Diastolic blood pressure          86 (14)       82 (15)       0.303
  Age at echocardiography, y        43 (12)       44 (13)       0.098
  Cardiovascular risk factors                                   
  Male sex                          15 (50)       15 (50)       1.000
  Hypertension                      9 (30)        3 (10)        0.146
  Diabetes mellitus, type 1         1 (3.3)       0             N/A
  Current smoking                   9 (30)        11 (36.7)     0.774
  Excessive alcohol use             9 (30)        3 (10)        0.031
  Physical inactivity               3 (10)        2 (6.7)       1.000
  Right‐to‐left shunt               22 (73.3)     10 (33.3)     0.002
  Cardiovascular medication usage                               
  Antiplatelets                     28 (93.3)     0             \<0.001
  Statins                           21 (70)       0             \<0.001
  Beta‐blockers                     3 (10)        0             0.250
  ACE inhibitors/ATR blockers       15 (50)       0             \<0.001
  Spironolactone                    1 (3.3)       0             1.000
  Other diuretics                   2 (6.7)       0             0.500
  Anticoagulant                     2 (6.7)       0             0.500

Body measurements: numbers are median (interquartile range); cardiovascular risk factors: numbers are n (%). For medication, numbers are n (%). ACE indicates angiotensin‐converting enzyme; ATR, angiotensin receptor; and N/A, not applicable.

Performance of Measurements {#jah34958-sec-0014}
---------------------------

LV basic measurements could be obtained in all study subjects, as were the diastolic measures of mitral inflow E and A. Also, septal and lateral e', as well as LAV index, could be obtained in all subjects. Tricuspid regurgitation velocity measurement was successful in 23 patients and 23 controls (both 76.7%). LAA orifice diameter measurements were successful in 29 case‐control pairs, LA volumetry in 30 pairs, LA speckle tracking epsilon analyses in 26 pairs, and tissue Doppler strain rate in 28 pairs.

Analysis of LV Systolic and Diastolic Function {#jah34958-sec-0015}
----------------------------------------------

LV basic measurements did not differ significantly between the 2 groups (Table [2](#jah34958-tbl-0002){ref-type="table"}). No study subjects had an average E/e' \>14. Three patients and 6 controls had impaired e' velocity of either the septal or lateral mitral annulus. One control subject and no patients had tricuspid regurgitation velocity of \>2.8 m/s. Five patients and 6 controls had enlarged LAV index, using the 34‐mL/m^2^ cut‐off value. None of the participants fulfilled more than one of the aforementioned criteria for evaluating diastolic function, and hence all patients and controls had a normal diastolic function according to American Society of Echocardiography/European Association of Cardiovascular Imaging criteria.

###### 

Comparison of Echocardiographic Findings Between Stroke Patients and Controls

                                                     Patients        Controls        *P* Value
  -------------------------------------------------- --------------- --------------- -----------
  LV basic measurements                                                              
  LV maximum internal diameter (diastolic), mm       49 (7)          50 (8)          0.413
  Interventricular septum diameter (diastolic), mm   10 (2)          10 (2)          0.609
  LV posterior wall diameter (diastolic), mm         8 (8--10)       9 (7--10)       0.776
  LV maximum internal diameter (systolic), mm        33 (7)          31 (7)          0.306
  LV end‐diastolic volume (4D), mL/m^2^              55.03 (17.40)   56.54 (20.40)   0.131
  LV end‐systolic volume (4D), mL/m^2^               20.97 (8.61)    23.67 (11.65)   0.125
  LV stroke volume, mL/m^2^ (4D)                     32.84 (13.19)   36.65 (12.84)   0.329
  LV ejection fraction (4D)                          62 (14)         59 (15)         0.462
  LAA orifice analysis                                                               
  LAA orifice minimum, mm/m^2^                       2.6 (1.6)       3.0 (1.9)       0.256
  LAA orifice maximum, mm/m^2^                       7.7 (4.0)       9.2 (3.0)       0.294
  LAA orifice variation, mm/m^2^                     5.49 (3.31)     6.64 (2.89)     0.265
  LAA orifice relative variation, %                  69 (19)         67 (16)         0.964
  LA volumetry                                                                       
  LA minimum volume, mL/m^2^                         10.6 (6.6)      10.5 (4.3)      0.558
  LA maximum volume, mL/m^2^                         25.9 (9.9)      27.5 (9.9)      0.136
  LA mid‐diastolic volume, mL/m^2^                   14.6 (6.3)      15.1 (7.2)      0.644
  LA late‐diastolic volume, mL/m^2^                  16.5 (7.0)      17.8 (7.9)      0.417
  LA reservoir volume, mL/m^2^                       10.2 (5.4)      13.2 (5.4)      0.030
  LA stroke volume, mL/m^2^                          4.78 (5.01)     6.32 (5.99)     0.517
  LA ejection fraction                               37.5 (26)       39.5 (18)       0.888
  LA cyclic volume change, mL/m^2^                   14.5 (8.8)      17.7 (5.8)      0.116
  LA conduit volume, mL/m^2^                         16.72 (13.66)   18.57 (16.74)   0.959
  LA passive emptying %                              55.9 (28.3)     63.2 (18.3)     0.428
  LA sphericity index                                0.355 (0.24)    0.29 (0.22)     0.198
  LA strain/epsilon analysis                                                         
  Negative epsilon peak                              12.58 (5.19)    14.13 (2.22)    0.322
  Positive epsilon peak                              17.8 (8.5)      20.8 (10.1)     0.023
  LA epsilon peak values negative/positive           0.68 (0.43)     0.64 (0.23)     0.367
  LA strain rate                                     −2.4 (0.8)      −2.8 (0.8)      0.014

Numbers are median (interquartile range). 4D indicates 4‐dimensional; LA, left atrium; LAA, left atrial appendage; and LV, left ventricular.

Analysis of LA Dynamics {#jah34958-sec-0016}
-----------------------

LA reservoir volume was significantly lower in the stroke patient group, as was the positive epsilon (Table [2](#jah34958-tbl-0002){ref-type="table"}). In analysis by tertiles, stroke patients differed from controls regarding LAA orifice variation (lowest tertile), LA cyclic volume change (lowest tertile), and LA strain rate (highest, ie, least negative, tertile; Table [3](#jah34958-tbl-0003){ref-type="table"}). In sensitivity analysis, LA cyclic volume change and LA reservoir volume were smaller in participants with right‐to‐left shunt than in those without (Table [4](#jah34958-tbl-0004){ref-type="table"}). Also, when analyzing the patient and control groups separately, we found no significant differences between patients with or without right‐to‐left shunt (Tables [S1 and S2](#jah34958-sup-0001){ref-type="supplementary-material"}).

###### 

Most Pathological Tertile Analysis of LA Echocardiographic Parameters Between Stroke Patients and Controls

                                                       Patients       Controls       *P* Value
  ---------------------------------------------------- -------------- -------------- -----------
  LAA orifice analysis                                                               
  LAA orifice minimum, mm/m^2^ (highest)               3.44 (0.90)    3.89 (0.54)    0.123
  LAA orifice maximum, mm/m^2^ (highest)               10.60 (3.46)   11.15 (0.82)   0.478
  LAA orifice variation, mm/m^2^ (lowest)              3.88 (0.75)    4.35 (0.90)    0.043
  LA volumetry                                                                       
  LA minimum volume, mL/m^2^ (highest)                 14.50 (2.26)   14.51 (2.50)   0.797
  LA maximum volume, mL/m^2^ (highest)                 30.95 (4.93)   34.03 (3.35)   0.270
  LA mid‐diastolic volume, mL/m^2^ (highest)           19.72 (7.03)   19.97 (3.02)   0.519
  LA late‐diastolic volume, mL/m^2^ (highest)          21.71 (6.14)   22.91 (3.49)   0.171
  LA reservoir volume, mL/m^2^ (lowest)                5.61 (3.01)    9.01 (2.57)    0.023
  LA stroke volume, mL/m^2^ (highest)                  10.16 (4.10)   10.57 (4.81)   0.748
  LA ejection fraction (lowest)                        21.5 (6.5)     26.5 (8.75)    0.362
  LA cyclic volume change, mL/m^2^ (lowest)            9.17 (2.84)    12.84 (3.52)   0.019
  LA conduit volume, mL/m^2^ (highest)                 23.75 (7.19)   26.53 (4.37)   0.945
  LA passive emptying % (lowest)                       37.1 (10.2)    39.7 (18.0)    0.326
  LA sphericity index (highest)                        0.51 (0.14)    0.48 (0.10)    0.165
  LA strain analysis                                                                 
  Negative epsilon peak (highest)                      17.35 (3.75)   15.5 (0.90)    0.554
  Positive epsilon peak (lowest)                       14.23 (0.41)   15.53 (3.08)   0.151
  LA epsilon peak values negative/positive (highest)   1.01 (0.10)    0.91 (0.25)    0.148
  LA strain rate (highest, ie, least negative)         −1.8 (0.55)    −2.3 (0.55)    0.021

Whether the highest or lowest tertile is considered the most pathological is expressed on each row after the parameter name. Numbers are median (interquartile range). LA indicates left atrium; and LAA, left atrial appendage.

###### 

Comparison of LA Findings in Patients and Controls, Based on Right‐to‐Left Shunt Status

  Patients and Controls                      PFO (+)        PFO (−)        *P* Value
  ------------------------------------------ -------------- -------------- -----------
  LAA orifice minimum, mm/m^2^               3.05 (1.63)    2.89 (1.91)    0.513
  LAA orifice maximum, mm/m^2^               8.72 (3.40)    8.83 (3.61)    0.533
  LAA orifice variation, mm/m^2^             5.81 (2.59)    6.17 (3.25)    0.369
  LAA orifice relative variation, %          66.7 (14.7)    71.4 (19.7)    0.286
  LA minimum volume, mL/m^2^                 9.42 (5.50)    11.08 (5.18)   0.351
  LA maximum volume, mL/m^2^                 25.19 (8.78)   27.21 (8.48)   0.083
  LA mid‐diastolic volume, mL/m^2^           13.94 (7.67)   15.15 (6.14)   0.266
  LA late‐diastolic volume, mL/m^2^          16.73 (8.25)   16.42 (6.11)   0.524
  LA reservoir volume, mL/m^2^               10.4 (5.3)     13.2 (6.6)     0.042
  LA stroke volume, mL/m^2^                  5.74 (5.83)    5.55 (5.01)    0.790
  LA ejection fraction                       40.5 (17.25)   39.0 (26.0)    0.947
  LA cyclic volume change, mL/m^2^           14.7 (7.0)     17.9 (6.1)     0.039
  LA conduit volume, mL/m^2^                 19.4 (10.9)    16.2 (16.9)    0.382
  LA passive emptying %                      55.1 (29.9)    63.3 (18.1)    0.100
  LA sphericity index                        0.29 (0.19)    0.35 (0.27)    0.604
  Negative epsilon peak                      13.7 (5.3)     13.5 (3.2)     0.915
  Positive epsilon peak                      19.8 (11.6)    20.4 (6.4)     0.762
  LA epsilon peak values negative/positive   0.68 (0.37)    0.64 (0.31)    0.922
  LA strain rate                             −2.6 (1.0)     −2.5 (0.7)     0.939

Numbers are median (interquartile range). LA indicates left atrium; LAA, left atrial appendage; and PFO, patent foramen ovale.

Discussion {#jah34958-sec-0017}
==========

To the best of our knowledge, this is the first study to investigate LA functional parameters in young cryptogenic stroke patients with advanced echocardiography. We selected stroke‐free young adults for our control group, in order to detect atrial risk factors for cryptogenic stroke in the general population, and to study whether atrial findings may play a role in cryptogenic stroke. We found the most obvious differences between patients and controls in early diastolic volume and strain changes, represented by LA reservoir volume and positive peak epsilon value. In analysis by tertiles, we further found that patients differed from controls with respect to LAA orifice variation, LA cyclic volume change, and LA strain rate. Part of the explanation of the difference in LA reservoir volume and LA cyclic volume change might be attributable to right‐to‐left shunt, given that these parameters reached statistical significance stratified by patent foramen ovale (±). However, this shunt is not continuous, and hence it seems probable that the volume differences are attributable to other reasons.

A recent study including older ESUS patients found that ESUS patients had lower LA emptying fraction and higher LA end‐diastolic (ie, minimum) volume, compared with healthy individuals.[20](#jah34958-bib-0020){ref-type="ref"} As in that study, our participants exhibited "supernormal" LA maximum volumes (patients, 25.7 mL/m^2^ versus controls, 28.6 mL/m^2^), given that the upper limit is regarded as slightly over 40/mL/m^2^ using the 4D volumetry method.[21](#jah34958-bib-0021){ref-type="ref"}, [22](#jah34958-bib-0022){ref-type="ref"} The differences in LAV variation can, in our case‐control study, be detected by differences in LA reservoir volume and positive epsilon and supported by the analysis by tertiles of LA cyclic volume change. However, unlike in the previous study,[20](#jah34958-bib-0020){ref-type="ref"} we did not find differences in LA sphericity index between patients and controls, which might be attributable to milder LA pathology in our younger population.

An earlier cardiac magnetic resonance imaging study including older patients found a trend of lower LAV change in stroke patients with undetermined stroke compared with patients with determined noncardiac causes. Interestingly, in that study, patients with undetermined stroke also had more atrial fibrosis detected by magnetic resonance imaging, despite no difference in LA maximum volume.[23](#jah34958-bib-0023){ref-type="ref"} Although all of our tertiles of both stroke patients and controls had normal LV ejection fraction, and no patients or controls fulfilled the criteria for diastolic dysfunction, there still might be differences in LV loading conditions attributed to subclinical diastolic dysfunction. However, a finding pointing strongly toward the altered LA dynamics being attributable to primary LA abnormality is the similarity in LAVmin between the groups, LAVmin being a sensitive marker of diastolic dysfunction.[24](#jah34958-bib-0024){ref-type="ref"} In the lack of knowledge on LV filling pressure and LA fibrosis, we cannot draw conclusions on whether the differences in LA dynamics are secondary to LV conditions or attributable to primary LA disease. However, because of that study\'s finding of more LA fibrosis in patients with otherwise similar LA dynamics as in our participants, we think it is likely that also younger cryptogenic stroke patients have slightly abnormal LA dynamics attributable to LA fibrosis (ie, representing primary LA disease).[23](#jah34958-bib-0023){ref-type="ref"} An explanation for why the difference emerged only in the volume change of LA is that atrial fibrosis dampens the LA\'s ability to stretch and contract and hence change its volume, although, in the lack of LV failure, there is no increased LV filling pressure to stretch the LA.

Another finding of ours that points toward primary atrial disease is the significant difference in the lowest tertiles of LA strain rate. In AF, contractility of the LA is also dampened, detected by strain rate.[25](#jah34958-bib-0025){ref-type="ref"} AF is well known to be associated with atrial fibrosis.[26](#jah34958-bib-0026){ref-type="ref"} Perhaps the lower contractility of atrial tissue in patients with paroxysmal AF is also attributable to atrial fibrosis. However, AF is unlikely in the age group of our patients, and hence it seems more probable that they only have mild atrial fibrosis. Our novel method of LAA orifice analysis from the apical projection has a similar profile as LAV and epsilon values: no differences in maximum values, but the variation between minimum and maximum values was lower in the stroke patient group. Interestingly, a larger LAA orifice diameter has been suggested as a stroke risk factor in general AF patients.[27](#jah34958-bib-0027){ref-type="ref"}

Strengths of our study include a systematic and well‐matched case‐control participant population, a prospective design, a precise protocol with very few missing data, blinding of the echocardiographist until all measurements were performed, and the use of modern echocardiography methods such as 4D volumetry and epsilon. The similar findings of lower LA variation, in both epsilon and volumetry in the stroke patient group, together with lowered strain rate, are findings that complement each other in the conclusion of altered LA dynamics. Weaknesses, in turn, include the small sample size, possible selection bias and other shortcomings inherent to case‐control studies, and lack of invasive LV filling pressure measurements. The small sample size also restricted our possibility to adjust for confounders. Thus, we could not firmly determine whether the differences in LA dynamics were of a primary nature or secondary to differing LV filling conditions.

Conclusions {#jah34958-sec-0018}
===========

Our pilot study showed that LA dynamics differed between young cryptogenic stroke patients and stroke‐free controls, when measured with advanced cardiac ultrasound techniques. However, there were only slight differences in some parameters and no differences in the rest. Future studies should include larger patient populations to increase discriminatory power, allow for relevant subgroup analyses (eg, stratified by patent foramen ovale status), and differentiating between primary atrial disease and secondary differences reflecting LV function.
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